🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05644548
Recruiting Observational

Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography

NCT05644548 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Tongren Hospital
Phase
Observational
Started
2022-03-01
Last updated
2025-09-25

Condition(s) studied

HypertensionDiabetes MellitusDyslipidemias

Investigational drug(s) / intervention(s)

No intervention

No intervention: No intervention

Study summary

Hypertension, diabetes mellitus, and dyslipidemia are common internal diseases, and all diseases are atherosclerosis risk factors. Previous studies applied color fundus photography to analyze retinal vascular changes (including exudation, hemorrhage, neovascularization, etc.) in patients with hypertension or diabetes, but the examination results could not be quantified.

This study intends to apply optical coherence tomography angiography (OCTA) to examine retinal vessels. This method has the following advantages: 1) It can quantify vascular changes, and 2) It is noninvasive and reproducible for patients' follow-up.

This study was designed to investigate retinal vascular changes in patients with hypertension, diabetes, and dyslipidemia on OCTA. We will collect the patients' general information (gender, age), comorbidities, medications, blood lipids, blood glucose, carotid ultrasound, ankle-brachial index, ambulatory blood pressure monitoring, color fundus photography, and OCTA results. We will follow up with the patients for five years and conduct the mentioned examinations once a year. We will also investigate the correlation between systemic atherosclerosis (such as coronary artery stenosis, and carotid artery stenosis) and retinal vasculopathy in patients with these diseases.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Patients with hypertension * Or patients with diabetes * Or patients with dyslipidemia * Agree to participate in this study Exclusion Criteria: * Patients with malignant tumors * Patients with autoimmune diseases * Patients with immunodeficiency disease * Disagree to participate in this study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Beijing Tongren Hospital Beijing Beijing Municipality Recruiting

More Beijing Tongren Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05644548 on ClinicalTrials.gov ↗ ← All trials in China